Residual activity after radioembolization of liver tumours with 90Y resin microspheres;Restaktivität nach Radioembolisation von Lebertumoren mit 90Y-Harzmikrosphären Eine sichere Methode zur Berechnung

NuklearMedizin

Volumn 53, Issue 3, 2014, Pages 95-98

  Ahmadzadehfar, Hojjat ^a   Haslerud, T ^a   Reichmann, K ^a   Meyer, C ^a   Habibi, E ^a   Fimmers, R ^b   Muckle, M ^a   Sabet, A ^a   Biersack, H J ^a   Ezziddin, S ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Dosimetry; Radioembolization; Resin microspheres

Indexed keywords

90Y RESIN MICROSPHERE; MICROSPHERE; UNCLASSIFIED DRUG; ACRYLIC ACID RESIN; DRUG CARRIER; RADIOPHARMACEUTICAL AGENT; YTTRIUM;

ARTICLE; DOSIMETRY; LIVER TUMOR; NONSURGICAL INVASIVE THERAPY; RADIATION DOSE; RADIOEMBOLIZATION; RADIOLOGICAL PROCEDURES; BRACHYTHERAPY; DRUG PACKAGING; HUMAN; LIVER NEOPLASMS; MEDICAL DEVICE CONTAMINATION; PROCEDURES; RADIATION ABSORPTION; RADIATION INJURIES; RADIATION PROTECTION; RADIOMETRY;

ABSORPTION, RADIATION; ACRYLIC RESINS; BRACHYTHERAPY; DRUG CARRIERS; DRUG PACKAGING; EQUIPMENT CONTAMINATION; HUMANS; LIVER NEOPLASMS; MICROSPHERES; RADIATION INJURIES; RADIATION PROTECTION; RADIOMETRY; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; YTTRIUM RADIOISOTOPES;

EID: 84903387390     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.3413/Nukmed-0585-13-05     Document Type: Article

References (12)

1. Ahmadzadehfar H, Muckle M, Sabet A et al. The significance of bremsstrahlung SPECT/CT after yttrium-90 radioembolization treatment in the prediction of extrahepatic side effects. Eur J Nucl Med Mol Imaging 2012; 39: 309-315.
2. Campbell AM, Bailey IH, Burton MA. Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol 2000; 45: 1023-1033.
3. Demers C, McMurray JJ, Swedberg K et al. Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure. JAMA 2005; 294: 1794-1798.
4. Elschot M, Vermolen BJ, Lam MG et al. Quantitative comparison of PET and Bremsstrahlung SPECT for imaging the in vivo yttrium-90 microsphere distribution after liver radioembolization. PloS one 2013; 8: e55742,
5. Giammarile F, Bodei L, Chiesa C et al. EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds. Eur J Nucl Med Mol Imaging 2011; 38: 1393-1406.
6. 90Y radioembolization. J Nucl Med 2012; 53: 559-566.
7. Lhommel R, Goffette P, Van den Eynde M et al. Yttrium-90 TOF PET scan demonstrates high-resolution biodistribution after liver SIRT. Eur J Nucl Med Mol Imaging 2009; 36: 1696.
8. 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres. Eur J Nucl Med Mol Imaging 2010; 37: 1654-1662.
9. Salem R, Thurston KG. Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. J Vasc Interv Radiol 2006; 17: 1251-1278.
10. 90Y-SIR spheres: radiobiologic considerations. J Nucl Med 2010; 51: 1377-1385.
11. TheraSphere® Yttrium-90 Glass Microspheres users manual, MDS Nordion.
12. 32P-glass microspheres for the treatment of hepatocellular carcinoma. J Gastrointestinal Surg 2010; 14: 858-866.